
April 3 (Reuters) - NRX Pharmaceuticals Inc NRXP.O:
HOPE THERAPEUTICS, INC. AND NRX PHARMACEUTICALS, INC. (NASDAQ:NRXP) ANNOUNCE SIGNING OF A TERM SHEET FOR STRATEGIC INVESTMENT FROM A GLOBAL MEDICAL DEVICE MANUFACTURER INTO HOPE
NRX: TERM SHEET CONTEMPLATES INVESTMENT OF $2.5 MILLION TO BUY SERIES A CONVERTIBLE PREFERRED STOCK AT $50 MILLION PRE-MONEY VALUATION